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Abstract
A 25-year-old woman with a history of kidney transplantation for lupus nephritis was referred for
the evaluation and management of a mass incidentally found on echocardiography. An oval and
pedunculated mass attached to the tricuspid valve was managed with nonsurgical treatment. No
symptoms and complications attributable to the mass developed. Three years later, the size of the
mass decreased. Here we report the case of a probable cardiac papillary fibroelastoma (PFE), a
mobile mass, with a stalk on the septal leaflet of the tricuspid valve that was managed for three
years without surgical treatment.
Background
A cardiac mass of the heart is not rare. It is usually found
incidentally on routine echocardiography, which provides
non-invasive diagnosis of a possible mass with informa-
tion on the location, attachment, shape, size, and mobil-
ity. Echocardiography plays a very important role in the
diagnosis of intracardiac masses. Papillary fibroelastoma
(PFE) is a benign cardiac tumor that has the potential to
cause life-threatening embolic events. Surgical excision of
the tumor is recommended for all patients who develop
symptoms, but the treatment of asymptomatic patients
with an echocardiographically identified PFE is still con-
troversial [1].
Case presentation
A 25-year-old woman was referred from the division of
nephrology for evaluation and management of a cardiac
mass found on a transthoracic echocardiogram (TTE). The
patient had a kidney transplant15 days ago for lupus
nephritis. Three years earlier, the echocardiogram revealed
mild mitral regurgitation, but no mass was noted on the
tricuspid valve and there was no transvalvular blood flow
abnormality. Chest X-ray, physical examination, and elec-
trocardiogram were within normal range. Laboratory
data, including work-up for infective endocarditis and sys-
temic lupus erythematosus (SLE) were unremarkable
except for antinuclear antibodies (ANA) 1:320 (homoge-
nous type) and anti-dsDNA antibodies (+). The ejection
fraction was normal and mild mitral regurgitation was
noted. The TTE showed an incidental finding of a 1.1 × 0.9
cm mass attached to the septal leaflet of the tricuspid valve
(Figure 1) [see Additional file 1]. Transesophageal
echocardiography (TEE) revealed a highly mobile, oval
mass that had a well-demarcated border with a stalk (Fig-
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removal of this mass. However, given the patients' co-
morbidities and her refusal to undergo surgery, she was
followed with conservative treatment, including anticoag-
ulation with heparin for two weeks. However, the mass
remained unchanged. The patient was followed at two
month intervals for three years after discharge from the
hospital. Each follow-up included the evaluation of symp-
toms. There were no symptoms or complications resulting
from the possible embolus. Three years later, the tricuspid
mass size was decreased on follow-up echocardiography
(Figure 3) [see Additional file 3].
Discussion
The PFE is the third most common primary tumor of the
heart and most frequently involves the cardiac valves [2].
PFEs have well-established echocardiographic characteris-
tics. The sensitivity and specificity of TTE were 88.9% and
87.8%, respectively, with an overall accuracy of 88.4% for
the detection of PFE ≥ 0.2 cm [3]. These include a round,
oval and irregularly shaped tumor, usually smaller than
1.5 cm, a stalk attachment to the endocardium, they are
mobile if attached by such a stalk, and often have a refrac-
tive appearance with areas of echo-lucency [3,4]. PFEs are
an avascular connective tissue core surrounded by a looser
matrix, with multiple adjacent fronds covered by endothe-
lium [3]. These masses must be differentiated from other
cardiac mass-like lesions such as myxomas, vegetation,
fibromas, Libman-Sacks vegetations, Lamble's excres-
cences, or thrombi. Myxomas are usually located in the
left atrium and originate from the mid portion of the
atrium [5]. Infective vegetations are usually associated
with clinical signs of endocarditis and valvular destruc-
tion, and may resolve or change in appearance over time
with treatment [6]. In our patient, the blood tests
obtained to rule out endocarditis were negative and spe-
cific-endocarditis symptoms were not noted. Fibromas
usually occur in children and young adults and typically
involve the left ventricle, right ventricle and septum [7].
Lamble's excrescences are considerably smaller and
broader-based than PFEs [8]. Thrombi are typically
located in the atrial appendage, associated with atrial
fibrillation and mitral valve disease or occur in regions
Modified four-chamber apical view showing an oval (1.1 × 0.9 cm in size) mass having refr ctive appearance with echolu-ent areas on t e septal leafle  of tricuspid vlaveFigur  1
Modified four-chamber apical view showing an oval 
(1.1 × 0.9 cm in size) mass having refractive appear-
ance with echolucent areas on the septal leaflet of 
tricuspid vlave. LA = left atrium; RA = right atrium; LV = 
left ventricle; RV = right ventricle.
Transesophageal echocardiography at 85° view showing a mass with a stalk in right atriumFigur  2
Transesophageal echocardiography at 85° view show-
ing a mass with a stalk in right atrium. LA = left atrium; 
RA = right atrium.
Three years later, modified four-chamber apical view show-ing a smaller mass (0.6 × 0.7 cm in size) in comparison with figure 1Fi ure 3
Three years later, modified four-chamber apical view 
showing a smaller mass (0.6 × 0.7 cm in size) in com-
parison with figure 1. LA = left atrium; RA = right atrium; 
LV = left ventricle; RV = right ventricle.Page 2 of 3
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usually secondary to myocardial infarction or cardiomy-
opathy and the echocardiographic finding has an irregular
or lobulated border and absence of a pedicle [9]. In this
patient, It was unlikely to be a thrombus because of the
location and features of the mass and the presence of a
stalk. Although the patient received anticoagulation treat-
ment with heparin, the mass size remained unchanged.
The Libman-Sacks vegetations are generally rounded and
sessile, less than 1 cm2 in size, almost exclusively seen on
the mitral and aortic valves and rarely on the right heart
valves; they have irregular borders, heterogeneous
echodensities and no independent motion. Most valves
with masses have associated thickening or regurgitation
[10].
Most PFEs are asymptomatic; rarely, they are diagnosed
because of cardiac symptoms or an embolic event [11].
There are no guidelines for the management of PFEs. No
data exist to evaluate the efficacy of anticoagulation or
antiplatelet therapy for patients with PFE, although it is
speculated that deposition of thrombotic material on the
tumors may add to the risk of microembolization [3].
However, as long as there are no definite contraindica-
tions to surgery, the only independent predictor of mor-
tality or non-fatal embolization is tumor mobility;
surgical excision is strongly recommended for patients
with a highly mobile PFE with a stalk [9]. Surgical inter-
vention was the first line treatment recommended for this
patient. However, there were no clinical manifestations
from the mass such as embolization, followed by heart
failure, and the patient refused surgery. And it was rela-
tively the small size mass in the right sided heart. There-
fore, the patient was followed closely for three years. There
is another case reported with a mobile PFE conservatively
managed for more than four years in the literature [1].
Conclusion
This patient illustrates the nonsurgical management of a
pedunculated tricuspid valvular mass, diagnosed by
echocardiography, suggesting a PFE. To develop guide-
lines for standard appropriate management of such
patients, randomized controlled trials to compare con-
servative with surgical management of patients with
asymptomatic PFE are needed.
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Additional file 1
Modified apical 4 chamber view. This is a movie clip, a highly mobile 
pedunculated mass attached to the septal leaflet of the tricuspid valve.




Transesophageal view. This is a movie clip, showing an oval mass.




Modified apical 4 chamber view. Another a movie clip, three years later, 
a smaller mass compared to Figure 1
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